Add BrightSurf on Google Email

Toxic injection with elastic band

Tc toxin complexes, used by bacteria like Yersinia pestis and Photorhabdus luminescens, have been imaged with atomic detail. The complexes use an elastic band-like protein chain to penetrate cell membranes, depositing toxic enzymes. This mechanism has potential applications in medicine, including selectively targeting cancer cells.

SourceMax-Planck-Gesellschaft·JournalNature·DateFeb 24, 2014

MD Anderson researcher uncovers some of the ancient mysteries of leprosy

A new hypothesis suggests that leprosy has existed for millions of years, with roots dating back to around 10 million years ago. The disease is believed to have evolved from a common ancestor of two known leprosy bacteria, which underwent reductive evolution resulting in a lean genome and loss of free-living ability.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalPLOS Neglected Tropical Diseases·DateFeb 20, 2014

Prickly protein

Researchers discovered a genetic mechanism controlling the production of a large spike-like protein on staph bacteria that prevents clumping and reduces disease-causing ability. The study suggests targeting clumping behavior for therapy, potentially reducing staph infections.

SourceUniversity of Iowa Health Care·JournalPLOS Pathogens·DateFeb 6, 2014

New test targets salmonella

Researchers at Rice University have developed a novel biosensor that can detect multiple strains of salmonella pathogens in food quickly and easily. The sensor uses microcantilevers decorated with peptides to identify the presence of specific bacteria, delivering results within minutes and outperforming existing standard tests.

SourceRice University·JournalAnalytical Chemistry·DateJan 21, 2014

Typhoid fever -- A race against time

Researchers at the University of Basel have discovered how Salmonella bacteria outsmart the host's immune cells, allowing them to survive and spread infection. This knowledge may lead to new treatments for typhoid fever, a life-threatening disease affecting millions worldwide.

SourceUniversity of Basel·JournalCell Host & Microbe·DateJan 16, 2014

1 species, 2 outcomes: Team seeks source of body louse pathology

A new study found that the human body louse can transmit bacterial infections to humans, while the human head louse does not. The researchers discovered that several immune genes were regulated differently in head and body lice after infection with the bacteria, and the infection progressed further in body lice over time.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalInsect Molecular Biology·DateJan 10, 2014

Essential factor for Lyme disease transmission identified

Researchers found that HrpA is essential for Lyme disease transmission and tick survival, enabling the bacterium to regulate its RNA and survive in mammalian hosts. The discovery provides significant insights into the complex life cycle of Borrelia burgdorferi and potential targets for future treatments.

SourcePLOS·JournalPLOS Pathogens·DateDec 19, 2013

From friend to foe: How benign bacteria evolve to virulent pathogens

In a groundbreaking study, researchers found that benign E. coli bacteria can evolve to become pathogenic within 500 generations or 30 days when confronted with macrophages. The bacteria adapted by developing resistance to being killed by immune cells and acquiring traits similar to those of deadly pathogens.

SourcePLOS·JournalPLOS Pathogens·DateDec 12, 2013

Hydrogen-powered invasion

Researchers discovered that Salmonella Typhimurium obtains energy for its attack by stealing hydrogen from the microbiota. This 'theft-based hydrogen economy' allows the pathogen to find an energy source in any new animal host.

SourceETH Zurich·JournalCell Host & Microbe·DateDec 11, 2013

Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments

Scientists from the University of Ottawa and University of Calgary have shown that the bacterium Pseudomonas aeruginosa has genetically evolved to survive in CF-infected lungs and evade antibiotic treatments. The study provides new insights into the evolution of the pathogen, which is a major driver of cystic fibrosis mortality.

SourceUniversity of Calgary·JournalProceedings of the National Academy of Sciences·DateDec 11, 2013

UCI, Northwestern researchers create compounds that boost antibiotics' effectiveness

UC Irvine and Northwestern researchers develop inhibitor compounds that inhibit neuronal nitric oxide synthase, enhancing the ability of antibiotics to treat bacterial diseases. The compounds demonstrate potential in combating diseases such as MRSA and anthrax by suppressing pathogenic bacteria's resistance to antibiotics.

SourceUniversity of California - Irvine·JournalProceedings of the National Academy of Sciences·DateNov 25, 2013